KLRG1

KLRG1 Overview

English NameKiller cell lectin-like receptor subfamily G member 1Approved Drugs0
Drugs in Clinical Trials1Target SynonymC-type lectin domain family 15 member A,ITIM-containing receptor MAFA-L,MAFA-like receptor,Mast cell function-associated antigen,CLEC15A,MAFA,MAFAL
Highest Development StagePhase 3 Clinical
English NameKiller cell lectin-like receptor subfamily G member 1
Target SynonymC-type lectin domain family 15 member A,ITIM-containing receptor MAFA-L,MAFA-like receptor,Mast cell function-associated antigen,CLEC15A,MAFA,MAFAL
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 3 Clinical

KLRG1 Product List

  • Product Category

    Protein (5)

  • Product Status

    Launched (5)

  • Species

    Human (1)Mouse (1)Cynomolgus (3)

  • Tag

    His Tag (3)Fc Tag (1)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (4)Biotin-labeled (1)

KLRG1 Background

The co-inhibitory receptor killer-cell lectin like receptor G1 (KLRG1) is specifically expressed on NK cells and activated CD8+ T-cells and has been postulated to be a marker of senescence. KLRG1+ T cells are a major reason of chronic tissue damage in some autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. In tumors, tumor cells which express E-cadherin or N-cadherin bind to KLRG1 and inhibit the antitumor activity of T and NK cells. Thus, KLRG1 acts as an immunocheckpoint inhibitory receptor.

KLRG1 Synonyms

KLRG1

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
UlviprubartABC008; ABC-008Phase 3 ClinicalAbcuro IncLeukemia, Large Granular Lymphocytic; Myositis, Inclusion Body
Details
  • Overview
  • Product List
  • Clinical Drug Information